Usefulness of checking platelet count before thrombolysis in acute ischemic stroke

Stroke. 2007 May;38(5):1639-40. doi: 10.1161/STROKEAHA.106.480889. Epub 2007 Mar 22.

Abstract

Background and purpose: Thrombolysis for acute ischemic stroke is strikingly time sensitive. Current guidelines require confirmation of a platelet count > or =100,000 before thrombolysis; however, obtaining this laboratory test may delay treatment.

Methods: We queried our hospital database to identify patients with ICD-9 codes consistent with acute ischemic stroke from 2000 to 2005 and to determine platelet counts in these patients. Medical charts of patients with platelet counts <100,000 were reviewed to determine whether the patient had a known history of thrombocytopenia or conditions associated with thrombocytopenia.

Results: A total of 1752 patients were identified, and 82 (4.7%) had a platelet count <100,000 at stroke onset. Only 6/1752 (0.3%) had a platelet count <100,000 which was not suspected based on initial history. All of these 6 patients had only mildly decreased platelet counts.

Conclusions: An unsuspected platelet count <100,000 was found in 0.3% of patients at stroke presentation. In patients without a history of thrombocytopenia or predisposing factors, the benefit of earlier thrombolysis may outweigh the bleeding risk of inadvertently treating a patient with thrombocytopenia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Platelet Count*
  • Stroke / drug therapy*
  • Thrombolytic Therapy
  • Time Factors

Substances

  • Fibrinolytic Agents